Abstract
Non-steady-state drug concentrations and concomitant pharmacological effects are an attractive data source for learning about dose-response, because experiments can be done quickly, and hence in available clinical settings. However a potential pitfall of this kind of experiment is clear from a plot of effect and drug observations vs time: often the two resulting curves seem to be “out of phase”. To give an example, the upper panels of Figure 1 show simulated data with the maximal value of the effect occurring before the maximal drug concentration. The reverse situation is shown in the lower panels of Figure 1: the maximal value of the effect occurs after the maximal drug concentration. In either case a plot of observed effects (connected in time order) vs observed drug concentration describes a loop. A “literal” interpretation of such a plot suggests that different effect levels occur at the same drug concentration level (at different times).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akaike, H. (1974). A new look at the statistical model identification. IEEE Trans. Automat.Contr., 19:716–723
Bates, D. M. and D. G. Watts (1988). Nonlinear Regression Analysis and its Applications. John Wiley & Sons, New York.
Buja, A., T. Hastie, and R. Tibshirani (1989). Linear smoothers and additive models (with discussion). Ann. Stat.,17:453–555.
Campbell, D. B. (1990). The use of kinetic-dynamic interactions in the evaluation of drugs, Psychopharmacology,100:433–450.
Carson, E. R., C. Cobelli, and L. Finkelstein (1983). The Mathematical Modeling of Metabolic and Endocrine Systems. John Wiley & Sons, New York.
Covell, D. G., M. Berman, and C.Delisi (1984). Mean residence time-theoretical development, experimental determination, and practical use in tracer analysis. Math. Biosci., 72:213–244.
DeBoor, C. (1978). A Practical Guide to Splines,. Springer-Verlag, New York.
Fuseau, E. and L. B. Sheiner (1984). Simultaneous modelling of pharmacokinetics and pharmacodynamics with a nonparametric pharmacodynamie model. Clin. Pharmacol. Ther.,35:733–741.
Gibaldi, M. and D. Perrier (1982). Pharmacokinetics2nd edition, Marcel Dekker, New York.
Hammes, G. G. (1982). Enzyme Catalysis and Regulation. Academic Press, New York.
Hull, C. J., B. H. VanBeem, K. McLeod, A. Sibbald, and M. J. Watson (1978). A pharmacokinetic model for pancuronium. Br. J. Anesthes., 50:1113–1123.
Porchet,H. C., N. L. Benowitz, L. B. Sheiner, and J. R. Copeland (1988). Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics. J. Clin. Invest., 244:231–236.
Segre, G. (1968). Kinetics of interaction between drugs and biological systems. Il Farmaco, 23:907–918.
Sheiner, L. B. (1989). Clinical pharmacology and the choice between theory and empiricism. Clin. Pharmacol. Ther., 46:605–615.
Unadkat, J. D., F. Bartha, and L. B. Sheiner (1986). Simultaneous modelling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models. Clin. Pharmacol.Ther., 40:86–93.
Veng-Pedersen, P. and W. R. Gillespie (1988). A system approach to pharmacodynamics I: theoretical framework. J. Pharm. Sci..77:39–47.
Veng-Pedersen, P., J. W. Mandema, and M. Danhof (1991). A system approach to pharmacodynamics IlI: an algorithm and computer program COLAPS for pharmacodynamic modeling. J Pharm. Sci,80:488–495.
Verotta, D. (1989). An inequality-constrained least-squares deconvolution method. J. Pharmacokinet. Biopharm.,19:269–289.
Verotta, D. and L. B. Sheiner (1987). Simultaneous modeling of pharmacokinetics and pharmacodynamics IV: an improved algorithm. Comput. Applicat. Biosci., 3:345–349.
Verotta D. and L. B. Sheiner (1988). Parametric and semi-parametric approaches to nonsteadystate pharmacokinetic and pharmacodynamic data. Biomedical Measurement InformaticsControl. 2:161–169.
Verotta, D. and L. B. Sheiner (1991a). Semiparametric models of the time course of drug action,” in C. J. Van-Boxtel, M. Danhof, and N. H. G. Holford, Eds. The In Vivo Study of Drug Action: Principles and Applications of Kinetic Dynamic Modelling. Elsevier Science Publishers, Amsterdam.
Verotta, D. and L. B. Sheiner (199 lb). Semiparametric analysis of non-steady-state pharmacodynamic data. J. Pharmacokinet. Biopharm., 19:691–712.
Verotta, D. S. Beal, and L. B. Sheiner (1989). Semiparametric approach to pharmacokinetic pharmacodynamic data. Am. J. Physiol., 256 (Regulatory Integrative Comp. Physiol. 25 ): R1005–R1010.
Verotta, D., L. B. Sheiner, and S. L. Beal (1991). Mean time parameters for generalized physiological flow models (semi-homogeneous linear systems). J. Pharmacokinet. Biopharm.,19:319–331.
Wegman, E. J., and L. W. Wright (1983). Splines in statistics. J. Am. Stat. Assoc.,78:351–365.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Verotta, D., Sheiner, L.B. (1993). Pharmacokinetic/Pharmacodynamic Models and Methods. In: Yacobi, A., Skelly, J.P., Shah, V.P., Benet, L.Z. (eds) Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1520-0_18
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1520-0_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1522-4
Online ISBN: 978-1-4757-1520-0
eBook Packages: Springer Book Archive